Top Story

Once-daily netarsudil noninferior to twice-daily timolol in phase 3 study

August 21, 2019

Graybug Vision completes Series C financing

August 21, 2019
Graybug Vision has closed $80 million in Series C financing, which will be used to advance its pan-VEGF inhibitor GB-102 into phase 2 studies and its potential glaucoma…

One health system’s experience relevant to looming price transparency rule

August 21, 2019
The Trump administration’s ongoing effort to lower health care costs and increase transparency resumes later this summer when HHS is expected to propose a rule…

Omeros posts lower net loss in second quarter

August 21, 2019
Omeros reported a second quarter net loss of $14.5 million, or $0.29 per share, compared with a net loss of $33.7 million, or $0.70 per share, in the second quarter of…

BLOG: Disrupting your surgical referrals

August 20, 2019
One concern shared with me by eye surgeons is what would happen to surgical volume if referral sources are pulled away. That threat may still be far off in the distance…
More Headlines »
Case Report

Bilateral Diffuse Uveal Melanocytic Proliferation Associated With Bladder Cancer: A Novel Imaging Finding

Ophthalmic Surgery, Lasers and Imaging Retina, August 2019, Volume 50 Issue 8
The authors report a case of bilateral diffuse uveal melanocytic proliferation associated with transitional cell…
More »

Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery

This activity is supported by an educational grant from Genentech, Inc.

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of…
More »
Resource Centers
American Society of Retina Specialists Meeting

American Society of Retina Specialists Meeting


Laser plus phaco for dense cataracts enhances safety, visual outcomes

Ocular Surgery News U.S. Edition, August 10, 2019
Marjan Farid, MD
More »